Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$2.0 million.

  • SOPHiA GENETICS's Cash from Financing Activities fell 7218.37% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year increase of 19586.46%. This contributed to the annual value of $11.6 million for FY2024, which is 51125.31% up from last year.
  • As of Q3 2025, SOPHiA GENETICS's Cash from Financing Activities stood at -$2.0 million, which was down 7218.37% from $33.5 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Cash from Financing Activities registered a high of $237.7 million during Q3 2021, and its lowest value of -$2.0 million during Q3 2025.
  • For the 5-year period, SOPHiA GENETICS's Cash from Financing Activities averaged around $14.5 million, with its median value being -$580000.0 (2022).
  • As far as peak fluctuations go, SOPHiA GENETICS's Cash from Financing Activities plummeted by 36681.03% in 2023, and later surged by 218756.06% in 2024.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Cash from Financing Activities stood at -$447000.0 in 2021, then fell by 29.75% to -$580000.0 in 2022, then increased by 12.76% to -$506000.0 in 2023, then soared by 210.67% to $560000.0 in 2024, then plummeted by 454.82% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, $33.5 million for Q2 2025, and -$990000.0 during Q1 2025.